A drug needs to go through four phases of clinical trials, with at least six to seven hundred million in investment. Even though Hezhi is not a small pharmaceutical company, they still wouldn't dare pursue the development of three new drugs simultaneously. The risk is too high; that's not a choice a mature entrepreneur should make.
Therefore, Huang Jianzhong and Huang Tianxuan discussed it and decided to release the clinical data reports of several drugs by mid-last month, hoping to attract investment to share the risk and accelerate the drug launching process to seize the opportunity.
Zheng Ling and her daughter are the capital attracted by this. They were coming to Hangzhou with the social club for a wedding as a side trip, but their real purpose was to negotiate an investment cooperation with Hezhi.
